| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |